Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lupus
lupus
Did Merck KGaA’s aging atacicept just fail a PhIIb lupus trial? Well, yes, but…
Endpoints
Mon, 11/14/16 - 11:16 am
Merck KGaA
atacicept
lupus
clinical trials
Anthera shares slump after lupus trial failure
BioPharma Dive
Sat, 11/12/16 - 09:06 am
Anthera
lupus
blisibimod
Facing questions on patient deaths, Aurinia shares crater in wake of PhIIb
Endpoints
Mon, 08/15/16 - 10:01 am
patient deaths
patients
Aurinia
clinical trials
voclosporin
lupus
Biogen sneaks previously unknown lupus drug into the clinic
Fierce Biotech
Wed, 07/13/16 - 02:10 pm
Biogen
lupus
BIIB068
Promising Lupus Drug From XTL Could Be Life Changer In Projected $4 Billion Market
Seeking Alpha
Wed, 06/1/16 - 10:50 am
lupus
XTL Bipharmaceuticals
GSK's lupus drug finally wins NICE backing, but only after discounts
BioPharma Dive
Thu, 05/12/16 - 09:40 am
GSK
lupus
NICE
UK
Benlysta
AstraZeneca may have a lupus blockbuster-in-waiting
BioPharma Dive
Wed, 11/11/15 - 09:29 pm
lupus
AstraZeneca
anifrolumab
AstraZeneca, GlaxoSmithKline stake rival claims on new lupus therapies
Fierce Biotech
Wed, 11/11/15 - 09:56 am
AstraZeneca
GSK
lupus
Benlysta
MEDI-546
UCB's lupus trial fails in final clinical tests
Yahoo/Reuters
Tue, 07/28/15 - 10:01 am
UCB Pharma
lupus
epratuzumab
Growing Seattle Genetics tests cancer therapy for treatment of lupus
Bizjournals.com
Thu, 07/9/15 - 07:49 pm
Seattle Genetics
lupus
Adcetris
AstraZeneca lupus drug produces positive results in trial
Yahoo/Reuters
Mon, 11/17/14 - 08:31 am
AstraZeneca
lupus
Benlysta
sifalimumab
Eli Lilly to drop development of lupus drug
Yahoo/Reuters
Thu, 10/2/14 - 09:35 am
Eli Lilly
lupus
tabalumab
AstraZeneca reports mavrilimumab, sifalimumab studies met primary endpoints
The Fly on the Wall
Mon, 05/12/14 - 11:51 am
mavrilimumab
sifalimumab
AstraZeneca
MedImmune
lupus
autoimmune disease
rheumatoid arthritis
GlaxoSmithKline hits the brakes on an anti-inflammatory drug from Galapagos
Fierce Biotech
Mon, 03/3/14 - 10:31 am
GSK
Galapagos
GSK2586184
lupus
A Promising Future For Anthera's Blisibimod
Seeking Alpha
Sat, 09/28/13 - 12:16 pm
lupus
blisibimod
Anthera
Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
Yahoo
Thu, 03/28/13 - 08:47 am
blisibimod
Anthera
lupus
Anthera Pharmaceuticals Trading Higher On Additional Data; Need For Capital Could Cap Upside
Seeking Alpha
Thu, 11/29/12 - 10:41 am
Anthera
lupus
blisibimod
Anthera's Lupus Drug Gets Second Chance After Clinical Trial Disaster
Seeking Alpha
Wed, 11/14/12 - 12:14 pm
Anthera
lupus
blisibimod
Anthera announces advancement of blisibimod in Phase 3 development
The Fly on the Wall
Mon, 09/17/12 - 10:09 am
blisibimod
Anthera
lupus
Anthera plunges on drug study
Marketwatch
Thu, 06/28/12 - 12:47 pm
Anthera
blisibimod
lupus
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »